{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:17:50Z","timestamp":1790399870247,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejmech.2020.112766","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T01:38:41Z","timestamp":1598060321000},"page":"112766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors"],"prefix":"10.1016","volume":"208","author":[{"given":"An\u017ee","family":"Meden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-1384","authenticated-orcid":false,"given":"Damijan","family":"Knez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-7768","authenticated-orcid":false,"given":"Natalia","family":"Malikowska-Racia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-1032","authenticated-orcid":false,"given":"Xavier","family":"Brazzolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-3595","authenticated-orcid":false,"given":"Jurij","family":"Svete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Sa\u0142at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uro\u0161","family":"Gro\u0161elj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-3083","authenticated-orcid":false,"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112766_bib1","series-title":"World Alzheimer Report 2019: Attitudes to Dementia","author":"Alzheimer\u2019s Disease International","year":"2019"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112766_bib2","first-page":"321","article-title":"Alzheimer\u2019s disease facts and figures","volume":"15","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ejmech.2020.112766_bib3","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primer"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","article-title":"Reconsideration of anticholinesterase therapeutic strategies against Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.ejmech.2020.112766_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer\u2019s disease; current status and new perspectives","volume":"2","author":"Scarpini","year":"2003","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","article-title":"The history of the cholinergic hypothesis","volume":"221","author":"Contestabile","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer\u2019s disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Transl. Neurodegener."},{"issue":"7","key":"10.1016\/j.ejmech.2020.112766_bib9","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer\u2019s disease drug development pipeline:","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"issue":"526","key":"10.1016\/j.ejmech.2020.112766_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6931","article-title":"\u03b2-Amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2\/tau cascade","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A\u00a0critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2020.112766_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of amyloid-\u03b2 peptide hint at new ways to treat Alzheimer\u2019s disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112766_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1185\/03007990152673800","article-title":"A\u00a0new therapeutic target in Alzheimer\u2019s disease treatment: Attention to butyrylcholinesterase","volume":"17","author":"Greig","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2020.112766_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"S1","key":"10.1016\/j.ejmech.2020.112766_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer\u2019s disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112766_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12031-013-0183-5","article-title":"Acetylcholinesterase protein level is preserved in the Alzheimer\u2019s brain","volume":"53","author":"Campanari","year":"2014","journal-title":"J.\u00a0Mol. Neurosci."},{"issue":"23","key":"10.1016\/j.ejmech.2020.112766_bib18","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in\u00a0vitro","volume":"103","author":"Diamant","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.06.053","article-title":"N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine","volume":"572","author":"Cerbai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in\u00a0vivo activity","volume":"61","author":"Ko\u0161ak","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112766_bib21","doi-asserted-by":"crossref","first-page":"39495","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"issue":"97","key":"10.1016\/j.ejmech.2020.112766_bib22","doi-asserted-by":"crossref","first-page":"14574","DOI":"10.1039\/C9CC07737E","article-title":"A\u00a0fluorescent probe for butyrylcholinesterase activity in human serum based on a fluorophore with specific binding affinity for human serum albumin","volume":"55","author":"Yoo","year":"2019","journal-title":"Chem. Commun."},{"issue":"25","key":"10.1016\/j.ejmech.2020.112766_bib23","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1021\/jm060742o","article-title":"Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase","volume":"49","author":"Elsinghorst","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112766_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2020.112766_bib25","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer\u2019s disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"issue":"36","key":"10.1016\/j.ejmech.2020.112766_bib26","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1021\/bi300955k","article-title":"Probing the peripheral site of human butyrylcholinesterase","volume":"51","author":"Macdonald","year":"2012","journal-title":"Biochemistry"},{"issue":"42","key":"10.1016\/j.ejmech.2020.112766_bib27","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"48","key":"10.1016\/j.ejmech.2020.112766_bib28","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.1021\/bi971425+","article-title":"Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase","volume":"36","author":"Saxena","year":"1997","journal-title":"Biochemistry"},{"issue":"45","key":"10.1016\/j.ejmech.2020.112766_bib29","doi-asserted-by":"crossref","first-page":"12074","DOI":"10.1021\/bi00096a018","article-title":"Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors","volume":"32","author":"Radic","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112766_bib30","doi-asserted-by":"crossref","first-page":"108698","DOI":"10.1016\/j.cbi.2019.06.011","article-title":"A\u00a0new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies","volume":"309","author":"Gerlits","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"26","key":"10.1016\/j.ejmech.2020.112766_bib31","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1039\/C9CC01330J","article-title":"Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer\u2019s disease","volume":"55","author":"Meden","year":"2019","journal-title":"Chem. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2020.112766_bib32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jfluchem.2009.07.008","article-title":"A\u00a0new synthetic route to polyfluorobenzyl alcohol","volume":"130","author":"Zhang","year":"2009","journal-title":"J.\u00a0Fluorine. Chem."},{"key":"10.1016\/j.ejmech.2020.112766_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/047084289X.rn00682","article-title":"Pentafluorobenzoic acid","author":"Prakash","year":"2006"},{"issue":"7","key":"10.1016\/j.ejmech.2020.112766_bib34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1139\/v02-083","article-title":"Sodium borohydride: a versatile reagent in the reductive N-monoalkylation of \u03b1-amino acids and \u03b1-amino methyl esters","volume":"80","author":"Verardo","year":"2002","journal-title":"Can. J. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2020.112766_bib35","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1021\/jm00150a020","article-title":"Synthesis and biological activities of some pseudo-peptide analogs of tetragastrin: the importance of the peptide backbone","volume":"28","author":"Martinez","year":"1985","journal-title":"J.\u00a0Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2020.112766_bib36","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112766_bib37","author":"Pesaresi"},{"issue":"8","key":"10.1016\/j.ejmech.2020.112766_bib38","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jalz.2005.09.004","article-title":"Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor","volume":"1","author":"Snyder","year":"2005","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbr.2008.10.029","article-title":"Evaluation of spatial memory of C57BL\/6J and CD1 mice in the Barnes maze, the multiple T-maze and in the Morris water maze","volume":"198","author":"Patil","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112766_bib41","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2006.04347.x","article-title":"Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity","volume":"100","author":"Hartmann","year":"2007","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.0014-2956.2001.02692.x","article-title":"Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase","volume":"269","author":"Nachon","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"16","key":"10.1016\/j.ejmech.2020.112766_bib43","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","article-title":"Human butyrylcholinesterase produced in insect cells: Huprine-based affinity purification and crystal structure","volume":"279","author":"Brazzolotto","year":"2012","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. Sect. D"},{"issue":"10","key":"10.1016\/j.ejmech.2020.112766_bib46","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic ligand builder and optimization workbench (ELBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10.1016\/j.ejmech.2020.112766_bib47","series-title":"ChemAxon","author":"MarvinSketch","year":"2020"},{"issue":"4","key":"10.1016\/j.ejmech.2020.112766_bib48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of it Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10.1016\/j.ejmech.2020.112766_bib49","series-title":"The PyMOL Molecular Graphics System","author":"Schr\u00f6dinger","year":"2020"},{"issue":"2","key":"10.1016\/j.ejmech.2020.112766_bib50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbr.2010.08.030","article-title":"Learning, memory and search strategies of inbred mouse strains with different visual abilities in the Barnes maze","volume":"216","author":"O\u2019Leary","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2011.11.050","article-title":"The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice","volume":"676","author":"Park","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112766_bib52","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pharep.2015.04.018","article-title":"The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice","volume":"67","author":"Sa\u0142at","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147733","article-title":"A\u00a0comprehensive behavioral test battery to assess learning and memory in 129S6\/Tg2576 mice","volume":"11","author":"Wolf","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112766_bib54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12640-018-9901-7","article-title":"Phencyclidine and scopolamine for modeling amnesia in rodents: direct comparison with the use of Barnes maze test and contextual fear conditioning test in mice","volume":"34","author":"Malikowska-Racia","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejmech.2020.112766_bib55","article-title":"Barnes maze, a useful task to assess spatial reference memory in the mice","volume":"2007","author":"Sunyer","year":"2007","journal-title":"Nat. Protoc. Exch."},{"key":"10.1016\/j.ejmech.2020.112766_bib56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2015.07.037","article-title":"Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: role of activity at NMDA receptor","volume":"99","author":"Sa\u0142at","year":"2015","journal-title":"Neuropharmacology"},{"issue":"15","key":"10.1016\/j.ejmech.2020.112766_bib57","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0960-894X(98)00358-8","article-title":"Synthesis and antibacterial in\u00a0vitro activity of novel analogues of nematophin","volume":"8","author":"Himmler","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112766_bib58","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3762\/bjoc.10.135","article-title":"Stereoselective synthesis of carbocyclic analogues of the nucleoside Q precursor (PreQ0)","volume":"10","author":"Llona-Minguez","year":"2014","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112766_bib59","article-title":"Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the Np Y5 receptor","author":"Block","year":"2001","journal-title":"WO2001085714A1"},{"issue":"4","key":"10.1016\/j.ejmech.2020.112766_bib60","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/ja01391a034","article-title":"\u03b2-vinyl piperidine","volume":"50","author":"Merchant","year":"1928","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.ejmech.2020.112766_bib61","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.bmcl.2017.09.056","article-title":"Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes","volume":"27","author":"Storer","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"18","key":"10.1016\/j.ejmech.2020.112766_bib62","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1016\/j.bmcl.2007.07.022","article-title":"A\u00a0distal methyl substituent attenuates mitochondrial protein synthesis inhibition in oxazolidinone antibacterials","volume":"17","author":"Renslo","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"22","key":"10.1016\/j.ejmech.2020.112766_bib63","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1021\/jm401047q","article-title":"Synthesis and evaluation of multi-target-directed ligands against Alzheimer\u2019s disease based on the fusion of donepezil and ebselen","volume":"56","author":"Luo","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112766_bib64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17518253.2016.1145744","article-title":"High-yielding method for preparation of Carbocyclic or N-containing heterocyclic \u03b2-keto esters using in situ activated sodium hydride in dimethyl sulphoxide","volume":"9","author":"Popovi\u0107-Djordjevi\u0107","year":"2016","journal-title":"Green Chem. Lett. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112766_bib65","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/ja00159a050","article-title":"Systematic study of a series of highly fluorescent rod-shaped donor-acceptor systems","volume":"112","author":"Hermant","year":"1990","journal-title":"J.\u00a0Am. Chem. Soc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420307388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420307388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:16:11Z","timestamp":1759328171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420307388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":65,"alternative-id":["S0223523420307388"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112766","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112766"}}